Figure 2From: The efficacy of a health-related quality-of-life intervention during 48 weeks of biologic treatment of patients with moderate to severe psoriasis: study protocol for a multicenter randomized controlled trial Per-protocol dose regimen schedule for etanercept in the treatment of moderate to severe psoriasis. Back to article page